Research Article
OATP1B1 Plays an Important Role in the Transport and Treatment Efficacy of Sorafenib in Hepatocellular Carcinoma
Figure 9
Histopathological observations of peritumoral tissues. Vascular endothelial growth factor (VEGF) levels and microvessel density (MVD) in peritumoral tissues of rats in the control and experimental groups after immunohistological staining and treatment with 50 mg/kg sorafenib for 20 days. VEGF expression and MVD counts in the experimental group were significantly lower than those in the control group (not treated with PCN). VEGF positive rate and MVD count in tumor-adjacent tissues were also significantly decreased in the experimental group ( vs. , vs. , respectively). Symbols represent rat models of hepatocellular carcinoma untreated (-) or treated (+) with PCN.